MedTrace Logo

Study of the Practice of Debiri in France

NCT03369041 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-08-19

No results posted yet for this study

Summary

In order to extract the profiles of patients receiving DEBIRI treatment at best, the investigators proposed the establishment of a national prospective cohort to collect information on the greatest number of patients treated with DEBIRI. This cohort will allow a better understanding of the effectiveness, tolerance, feasibility and differences of practices at national level for this approach. These data will assist in the development of clinical trials in situations that appear to be most promising in clinical practice.

Conditions

  • Colorectal Adenocarcinoma
  • Hepatic Metastases

Interventions

DRUG

Irinotecan-Eluting Beads

Sponsors & Collaborators

  • Federation Francophone de Cancerologie Digestive

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-03
Primary Completion
2022-10-15
Completion
2022-10-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369041 on ClinicalTrials.gov